002581.SZ
*ST未名
SZSE · Healthcare · C 制造业 · CN
CNY 5.21
−10.02%Year over year
Reported trailing growth
- Revenue
- -9.2%
- EBITDA
- —
- EBIT
- -39.6%
- EPS
- +8.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -8.4%
- EBITDA
- —
- EBIT
- -60.6%
- Net income
- +15.3%
- EPS
- +15.3%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026